世界の関節炎市場 – 業界動向と2030年までの予測

Get Exclusive Sample PDF of this Report Here

関節炎市場の分析と規模:

関節炎の罹患率の増加と技術の進歩により、関節炎治療の設計と機能が大幅に改善され、関節炎市場の成長への道が開かれました。関節炎市場は、いくつかの要因により着実に成長しています。まず、関節炎の新しい改善された治療オプションの開発が市場の原動力となっています。さらに、関節炎の治療における個別化医療への注目が高まっています。

Data Bridge Market Researchは、2022年に43億米ドルだった世界の関節炎市場は、2030年までに86.3億米ドルに急増し、予測期間中に9.10％のCAGRを達成すると分析しています。これは、生物学的製剤セグメントが関節炎市場のリウマチ薬タイプのセグメントを支配していることを示しています。技術の進歩により、さまざまな用途の迅速およびインプラント薬と治療法が開発されました。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制の枠組みも含まれています。

関節炎市場の範囲とセグメンテーション

Get Exclusive Sample PDF of this Report Here

市場の定義

世界の関節炎市場とは、関節の炎症と硬直を特徴とする筋骨格系の疾患群である関節炎の診断、治療、管理に関連する商業的および治療的状況を指します。関節炎は、あらゆる年齢層の人々に影響を及ぼす可能性のある一般的な慢性疾患で、痛み、運動障害、生活の質の低下を引き起こします。

世界の関節炎市場には、医薬品、生物製剤、医療機器、診断ツール、支持療法など、関節炎患者のニーズに対応することを目的としたさまざまな製品とサービスが含まれます。また、関節炎治療に関連する研究開発活動、臨床試験、規制枠組みも含まれます。

世界の関節炎市場の動向

ドライバー

• 関節炎の罹患率の増加

The rising prevalence of arthritis, including rheumatoid arthritis, osteoarthritis, and psoriatic arthritis, is a significant market driver. Factors such as aging populations, sedentary lifestyles, obesity, and genetic predisposition contribute to the growing number of arthritis cases worldwide.

• Growing Awareness and Diagnostics

There is an increasing awareness of arthritis and its impact on individuals' quality of life. This has led to improved diagnosis rates and early detection of the disease. Greater awareness among both patients and healthcare professionals helps in timely intervention and treatment, driving the demand for arthritis management solutions.

• Advancements Treatment Options

The arthritis market has witnessed significant advancements in treatment options, including pharmacological interventions, biological therapies, and non-pharmacological approaches such as physical therapy and exercise. These innovations have improved the management of arthritis, providing patients with more effective and personalized treatment options.

Opportunities

• Rising Biologic Therapies

Biologic therapies, such as tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and Janus kinase (J.A.K.) inhibitors, have revolutionized the treatment of arthritis. However, there is still room for improvement in efficacy, safety, and personalized treatment options. Developing innovative biologics with improved efficacy and reduced side effects can be a significant opportunity in the market.

• Rising Patient Education and Support:

Arthritis is a chronic condition that requires self-management and lifestyle modifications. Providing education, support, and resources to patients and their caregivers can improve treatment adherence and outcomes. Digital health platforms, mobile applications, and telemedicine services can significantly deliver patient education and support.

Restraints/Challenges

• High Treatment Costs

Arthritis management often requires long-term medication and therapy, which can be expensive. The high cost of treatment, including prescription medications, physical therapy, and surgeries, can be a significant barrier for patients, particularly in countries with limited access to healthcare or inadequate insurance coverage. Affordability issues can hinder patients' ability to receive necessary treatment and limit market growth.

• Limited Efficacy of Available Treatments

While various treatment options are available for arthritis, including non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic therapies, not all patients respond adequately to these treatments. Some patients may experience only partial relief of symptoms or no improvement at all. The limited efficacy of existing treatments can restrict market growth and drive the need for innovative therapies.

This global arthritis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global arthritis market contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed decision to achieve market growth.

Recent Development

• In December 2022, Merck KGaA, a leading science and technology company, announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, U.S.A, to discover novel antibody-drug conjugates (A.D.C.s) leveraging Mersana's proprietary Immunosynthen STING-agonist A.D.C. platform, directed against up to two targets
• In February 2023, Roche announced that it had expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities

Global Arthritis Market Scope

The global arthritis market is segmented on the basis of Rheumatoid Drug Type, Rheumatoid Treatment, Rheumatoid Diagnosis, Osteoarthritis Type, Osteoarthritis Treatment, Osteoarthritis Diagnosis, Route of Administration, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Rheumatoid Drug Type

• Biologics
• Non-Biologics
• Steroids
• Analgesics
• Glucocorticoids
• Others

Rheumatoid Treatment

• Synovectomy
• Tendon Repair
• Joint Fusion
• Symptomatic Treatment
• Intermediate Corticosteroid Therapies
• DMARD Therapies

Rheumatoid Diagnosis

• C.R.P. Test
• CCP
• ESR Test

Osteoarthritis Type

• Hip
• Spinal
• Knee
• Foot and Ankle
• Shoulder
• Hand

Osteoarthritis Treatment

• Medication
• Drugs
• Assistive Devices
• Surgery
• Therapy

Osteoarthritis Diagnosis

• Imaging
• Joint Fluid Analysis
• Others

Route of Administration

• Oral
• Parenteral

End user

• Hospitals,
• Clinics
• Household
• Medical Institutes
• Research Organizations,
• Others

Global Arthritis Market Regional Analysis/Insights

The global arthritis market is analyzed, and market size insights and trends are provided for product type, biomaterial, procedure, device type, application, and end-user, as referenced above.

The countries covered in the global arthritis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, the Rest of South America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of the Middle East and Africa.

North America dominates the arthritis market due to the presence of major key players, high disposable income, high healthcare expenditure, and a well-developed healthcare sector in this region.

 Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market-impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends and Porter’s five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global arthritis market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the Global arthritis market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the Global arthritis market. The data is available for the historical period 2015-2020.

Competitive Landscape and Global Arthritis Market Share Analysis

The global arthritis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the global arthritis market.

Some of the major players operating in the global arthritis market are:

• Johnson & Johnson Private Limited(U.S.)
• AbbVie Inc. (U.S.)
• Pfizer Inc. (U.S.)
• Amgen Inc. (U.S.)
• Bristol-Myers Squibb Company(U.S.)
• F. Hoffmann-La Roche Ltd.(U.S.)
• UCB S.A.(Belgium)
• Gilead Sciences, Inc. (U.S.)
•  ベーリンガーインゲルハイムインターナショナルGmbH（ドイツ）
• リリー(米国)
• サノフィ（フランス）
• ノバルティスAG（スイス）
• アストラゼネカ(米国)
•  アステラス製薬株式会社（日本）
• ガラパゴス NV (ベルギー)
• 大正製薬ホールディングス株式会社（イギリス）
• リジェネロン・ファーマシューティカルズ社（米国）
• スウェーデン・オーファン・バイオビトラムAB（出版）（スウェーデン）
• ABIOGEN PHARMA SpA（イタリア）
•  コロン・ティッシュジーン社（米国）
• アンピオ・ファーマシューティカルズ社（米国）
• メルク・シャープ・アンド・ドーム社（米国）
• グラクソ・スミスクライン（英国）

SKU-50145